Alderley Analytical is a GLP/GCP compliant bioanalytical Contract Research Organisation (CRO), based at the prestigious Alderley Park BioHub in Cheshire. We offer independent bioanalytical services to support your discovery, pre-clinical, clinical and post launch marketing projects.
Our clients include high growth and established biotech, pharma and CROs, around the world, who appreciate our bespoke tailored service and consultative approach. Our scientific management team has experienced life in large pharmaceutical companies and CROs, and ensures that all clients receive the same, high quality service irrespective of size. We understand the pressure to deliver critically important programmes and take the time to listen to your objectives then offer innovative solutions.
With a mission to support the rapid development of new drugs, we have created an agile company, responsive to client needs and where good communication is part of our DNA. Since our launch in 2014, we’ve grown quickly and have delivered a significant number of high profile bioanalytical projects.
We provide discovery and regulatory bioanalytical services to support the development of small and large molecule therapeutics and generics in all stages of the drug development process, from discovery to post launch marketing, including bioavailability and bioequivalence studies.
We are GLP and GCP accredited and our laboratory features state of the art equipment, including Waters Xevo TQ-S and TQD mass spectrometers coupled to Acquity I-Class UPLC systems operated using the new UNIFI software platform. We also have the Thermo Q-Exactive High Resolution Mass Spectrometer technology coupled to Vanquish UPLC.
The Alderley Analytical journey so far
September 2013 – Atomic birth!
Alderley Analytical is born from a tiny atom of an idea between our 4 founding scientists
February 2014 – Mass space walk.
Mass space walk.
We move into laboratory space at Alderley Park, Cheshire and purchase our first Mass Spectrometer machine (Xevo TQ-S Triple Quad)
Summer 2014 – Summer of love.
Summer of love.
Between June and September, we win our first non-regulatory, and then regulatory, contracts
September 2014 – Compliant.
Following our first inspection, we’re delighted to achieve our Good Laboratory Practice (GLP) certification
November 2014 – Award Winner.
We’re very proud to win the ‘Start-up of the year’ award at the North East Cheshire Business Awards
July 2015 – Investment.
We receive £300K equity investment from Alderley Park Ventures and The North West Fund for Biomedical. Press coverage here.
August 2016 – Viking Raid.
In a significant new business win, the company is chosen as the Preferred Provider for Bioanalysis to a mid-sized biotech company in the Nordic region
October 2016 – Should have gone to Spec savers.
Should have gone to Spec savers.
Our 3rd mass spectrometer arrives
November 2016 – Angels make Christmas come early.
Angels make Christmas come early.
We receive a second injection of £300K funding from angel investors and the directors enjoy being able to sleep soundly again
March 2017 – We’re in the money.
We’re in the money.
The business becomes profitable!
April 2017 – Coming of Age.
Coming of Age.
Our 18th employee joins us as our growth continues
May 2017 – May the fourth be with you
May the fourth be with you
4th Mass Spectrometer arrives
June 2017 – On the move again.
On the move again.
Our continued success and the ever-growing team means we have to move to even bigger premises at Alderley Park and purchase yet another mass spectrometer
September 2017 – An inspector calls
An inspector calls
A successful MHRA GLP inspection
October 2017 - Out with the old.
Out with the old.
We thought we needed a facelift so our new brand is officially launched